Joint workshop of EpiLipidNET WG2 and Stratagem COST Action
Multidrug resistant (MDR) solid tumour research meets lipidomics and epilipidomics research.
Members of two COST Actions: EpiLipidNET and Stratagem will participate in a joint online workshop on 18th October 2022, 3 pm CET.
The workshop intends to present the posibilities, stemming from the intersection of both research fields and to stimulate cooperation between researchers.
Time: Oct 18, 2022 03:00 PM Amsterdam, Berlin, Rome, Stockholm, Vienna
Join Zoom Meeting
link: https://tu-dresden.zoom.us/j/65100470825?pwd=d0tnQS9EOWM3dGNKR3NBNEZ0eEt1dz09
Meeting ID: 651 0047 0825
Passcode: pH=W0*i6
Agenda:
- 3:00–3:15 Introduction on EpiLipidNET: Pan-European Network in Lipidomics and EpiLipidomics – Rosario Domingues (University of Aveiro, Portugal) and Maria Fedorova (TU Dresden, Germany)
- 3:15 – 3:30 Introduction on STRATAGEM: New diagnostic and therapeutic tools against multidrug resistant tumours – Chiara Riganti (University of Turin, Italy)
- 3:30 – 3:50 Drugs & Lipids: from therapies to lipid disorders induction – Laura Goracci (University of Perugia, Italy)
- 3:50 – 4:10 Metabolite of the endocannabinoid precursor lipid N-arachidonoylphosphatidylethanolamine selectively inhibits mesenchymal tumor invasion of 3D spheroids Zsolt Balogi (University of Pécs, Hungary)
- 4:10 – 4:30 Effects of lipid raft disruption on APQ3 and NRF2 – Ana Cipak Gasparovic (Ruđer Bošković Institute, Croatia)
- 4:30 – 4:50 Microenvironment-mediated lipid metabolism reprogramming and anti-EGFR therapy resistance in squamous cell carcinoma of the head and neck – Valentin Van Den Bossche (Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), University of Louvain (UCL) Medical School, Cyril Corbet lab, Belgium)
- 4:50 – 5:10 ECI meet the speakers (breakout rooms) & breakout room for free discussion
- 5:10 Closing remarks
Brochure: [news post]
Back to Events / News